2021
DOI: 10.1111/ced.14680
|View full text |Cite
|
Sign up to set email alerts
|

Hidradenitis suppurativa in a transgender man

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…Mortimer et al discovered early on that female HS patients have an elevated testosterone and free androgen index [ 17 ]. There are three cases reported where cross-sex hormone therapy (CSHT) with testosterone resulted in an exacerbation or manifestation of HS [ 18 , 19 ]. In contrast to the above results, Harrison reports that there is no difference in testosterone between HS and healthy controls [ 20 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Mortimer et al discovered early on that female HS patients have an elevated testosterone and free androgen index [ 17 ]. There are three cases reported where cross-sex hormone therapy (CSHT) with testosterone resulted in an exacerbation or manifestation of HS [ 18 , 19 ]. In contrast to the above results, Harrison reports that there is no difference in testosterone between HS and healthy controls [ 20 ].…”
Section: Resultsmentioning
confidence: 99%
“…However, this connection has not yet been proven. A subdivision between hormone-dependent and hormone-dependent HS could be interesting in the future to provide further information, as well as that cross-sex hormone therapy worsens HS, showing that androgens should be considered in HS pathogenesis [ 18 , 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Gomez et al, in a review article, provided the reader with the key evidence and recommendations for caring for SGMs with HS [ 23 ]. In this context, the management of HS in transgender individuals may be even more challenging, as masculinizing hormone therapy might worsen HS lesions [ 24 , 25 ].…”
Section: Hs and Gendermentioning
confidence: 99%
“… 3 There are only 3 published cases of exogenous testosterone (ET) in association with either new-onset HS or exacerbation of existing HS. 4 , 5 Here, we conduct a cross-sectional evaluation of the risk of HS exacerbation within 6 months of initiating ET therapy in patients with preexisting HS diagnosis.…”
mentioning
confidence: 99%